Anomatic to open packaging plant at New Albany Business Park
25-Jul-2011
Packaging manufacturer Anomatic is expanding with a new facility in New Albany, Ohio.
Sartorius Stedim Biotech sees single-use gains in H1; North American revs dip
25-Jul-2011 By Gareth Macdonald
Sartorius Stedim Biotech (SSB) has revised its full year guidance after its range of single-use products drove revenue gains in the first half of 2011.
New Carticept injection delivery system increases safety and efficiency
UPDATE
25-Jul-2011 By Natalie Morrison
Carticept Medical has been given the Food and Drug Administration go-ahead to market its Navigator Delivery System (Navigator DS) in the US.
CDSCO issues new Form 40 draft guidance for API importers
25-Jul-2011 By Gareth Macdonald
India’s CDSCO has issued draft guidance designed to help active pharmaceutical ingredient (API) importers streamline the submission and registration process.
News from Paragon, Pantheon, Amgen and PharmaNet – People on the move
25-Jul-2011 By Natalie Morrison
Outsourcing-Pharma presents a round up of the latest appointments in the pharmaceutical outsourcing sector, will news from Paragon, Pantheon, Amgen and PharmaNet.
J&J suppliers need sustainability goals under new initiative
21-Jul-2011 By Nick Taylor
All strategic suppliers to J&J will need at least two publically-reported sustainability goals under a new initiative by the healthcare giant.
Lanxess doubling menthol raw material output to meet demand
21-Jul-2011 By Nick Taylor
Lanxess is doubling capacity at a German plant to meet rising demand for menthol, a product used as a pharma excipient and in personal care.
ClinStar expands in US with East Coast office
21-Jul-2011 By Natalie Morrison
Emerging market CRO ClinStar has lengthened its US reach with a new regional East Coast office.
Parexel & Icon downgraded amid strategic deal concerns
21-Jul-2011 By Nick Taylor
An equity analyst has downgraded Icon and Parexel, following the Irish CRO’s Q2 results, and warned that its “enthusiasm for strategic deals is waning”.
Icon prepares to take Pfizer staff but doesn’t want facilities
21-Jul-2011 By Nick Taylor
Pfizer plans to transfer staff, but not facilities, to Icon as part of the outsourcing deal struck by the companies.
BioFocus and IMD team up for natural drug discovery
21-Jul-2011
BioFocus and InterMed Discovery (IMD) have launched a joint venture in enhanced natural product discovery.
Rising costs hit Icon’s Q2 ahead of Pfizer deal hiring drive
20-Jul-2011 By Nick Taylor
Icon has posted a 40 per cent drop in operating income as an uptick in expenses dragged on second quarter results.
Sherpa opens new packaging plant in CA
20-Jul-2011 By Natalie Morrison
Sherpa has cut the ribbon on a new cGMP biotech clinical trial material packaging facility in San Diego.
Altogen service aims to speed gene mutation detection
20-Jul-2011 By Nick Taylor
Altogen Labs is offering pyrosequencing services to quickly provide characterisation of disease-related genetics in clinical research.
Round up of CMO deals
19-Jul-2011 By Nick Taylor
Outsourcing-Pharma presents a round up of recent contract manufacturing deals, including business at Lonza, JHP Pharmaceuticals and PCT.
Life Technologies improves siRNA technology 100-fold
19-Jul-2011 By Natalie Morrison
Life Technologies has developed new drug delivery technology for therapeutic applications that is 100 times more potent than previous formulations.
Hong Kong talks legal action after ordering GSK recall
19-Jul-2011
Hong Kong is considering legal action against GSK after antibiotic samples were found to contain plasticisers.
Granules and Ajinomoto OmniChem to open Indian API facility
19-Jul-2011 By Natalie Morrison
Granules and Ajinomoto OmniChem have teamed up to produce high value APIs and intermediates at a new Indian plant.
Alkermes - EDT merger to spark consolidation & strategic shift
19-Jul-2011 By Nick Taylor
EDT will accelerate its shift to proprietary products and consolidate to save $20m when its takeover by Alkermes closes.
PPD denies CRO merger report but confirms strategic review
19-Jul-2011
PPD has denied it is discussing a merger with another CRO but confirmed that it is reviewing its strategic plan.
18-Jul-2011 By Nick Taylor
Europe has proposed draft distribution guidance in response to globalisation and threats to the pharmaceutical supply chain.
Two projects win backing from CFTI
18-Jul-2011
Two projects have been selected for preclinical testing as part of the Cystic Fibrosis (CF)Technology Initiative (CFTI) in Canada.
CRO & clinical tech M&A round-up
18-Jul-2011 By Natalie Morrison
Outsourcing-Pharma presents a round-up of CRO M&A, including inVentiv closing the PharmaNet deal, Icon adding technology, and Bracket inking its first takeover.
New asthma treatment threatens inhaler companies
18-Jul-2011 By Natalie Morrison
A new oral medication for asthma sufferers could wipe out half of all business for inhaler manufacturers.
PPD reportedly considering a sale as results season nears
18-Jul-2011 By Nick Taylor
CRO financial results season begins this week amid reports PPD could be sold, with other service providers and private equity viewed as potential bidders.
Popsi Cube joins Medicen Paris Region in a bid to bag more clients
13-Jul-2011 By Natalie Morrison
CRO Popsi Cube has become an active member of Medicen Paris Region, a network of firms, research centres, universities, hospitals and economic development parks hosting biotechnology companies in the French capital.
Plastic fantastic for Gerresheimer in Q2, tubular glass revs dip
13-Jul-2011 By Gareth Macdonald
Gerresheimer saw strong demand for plastic systems and moulded glassware in the second quarter fiscal 2011, while tubular glass revenue dipped slightly.
INC in the big leagues after Kendle takeover
13-Jul-2011 By Natalie Morrison
INC Research has completed the acquisition of Kendle in its battle to become one of the top five contract research organisations (CRO).
FDA must be empowered to oversee supply chain; report
13-Jul-2011 By Nick Taylor
Congress must grant the FDA additional powers to bring oversight of manufacturing inline with shifts in production practices, according to a report.
13-Jul-2011 By Gareth Macdonald
US CRO Quintiles says that demand for rapid access to clinical trial data is driving the development of vendor neutral management systems.
BioTox scoops Bio-Quant as Apricus off-loads preclinical sectors
12-Jul-2011 By Natalie Morrison
BioTox Sciences is flexing its drug discovery and preclinical testing muscle after acquiring Bio-Quant from its owner Apricus Biosciences.
News from Aesica, SCM, Phlexglobal and Celerion – People on the move
12-Jul-2011 By Gareth Macdonald
Outsourcing-Pharma presents a round up of the latest appointments in the pharmaceutical outsourcing sector, which news from Aesica, SCM, Phlexglobal and Celerion.
Appointments at Merck Serono, Ascletis, Allon, Acura, Sangamo and ProStrakan – People on the move
12-Jul-2011 By Gareth Macdonald
in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at Merck Serono, Ascletis, Allon, Acura, Sangamo and ProStrakan.
12-Jul-2011 By Nick Taylor
Phillips Plastics is to expand into Europe and add primary packaging contract manufacturing capabilities by acquiring Medisize.
US team develops hydrogel capsule for multi-drug delivery
12-Jul-2011 By Natalie Morrison
Researchers at the Georgia Institute of Technology have pioneered a multi-compartment gel capsule that could be used to simultaneously deliver drugs of different types.
12-Jul-2011 By Nick Taylor
Cash-strapped countries are making biopharm consider a product’s fiscal benefits earlier in development, according to INC.
Contractors missing out on simulation benefits, say BioClinica and Paragon
11-Jul-2011 By Gareth Macdonald
CROs and CMOs reluctant to integrate simulation and forecasting into clinical supply strategies are missing out on significant financial benefits according to BioClinica and Paragon Solutions.
Sanofi selling CMO & in-house production site to Valeant
11-Jul-2011 By Nick Taylor
Valeant Pharmaceuticals is to buy a dermatology unit, including CMO and in-house production assets, from Sanofi.
EU should revoke licenses if emission caps exceeded; report
11-Jul-2011 By Nick Taylor
Production plants exceeding emission levels could have manufacturing authorisations revoked under EU GMP proposals made by Sweden.
Generic drugs win a thumbs up from animal lovers
11-Jul-2011
Generic drug production is on the up in animal heath care.
New synthetic cell membranes set to cut time and costs
11-Jul-2011 By Natalie Morrison
Costly and time consuming drug screening could soon be a thing of the past thanks to new easy-bake synthetic cell membranes made at the Institute of Materials Research and Engineering (IMRE).
Law enforcement must take apart fake drug networks; Lilly
11-Jul-2011 By Nick Taylor
Eli Lilly has called for law enforcement to find and dismantle the supply sources and distribution networks underpinning fake online pharmacies.
Corruption in DRAP after fall of Pakistan Ministry of Health
07-Jul-2011
Lobbyists are battling to gain control of Pakistan’s new Drug Regulatory Agency (DRAP) after its Ministry of Health fell last week.
FDA bans import of products from Dr Reddy’s Mexico site
07-Jul-2011
The US Food and Drug Administration (FDA) has followed up a warning letter by banning imports from Dr Reddy’s Mexican API plant.
Interactive map shows cancer burden on CEE
07-Jul-2011 By Nick Taylor
Central and Eastern Europeans face, with some exceptions, a higher cancer mortality risk than their western European counterparts.
Interactive map of cancer mortality risk around the world
07-Jul-2011 By Nick Taylor
Outsourcing-Pharma presents an interactive map of mortality risk for major cancers around the globe.
Another J&J Tylenol recall
07-Jul-2011 By Natalie Morrison
Tylenol Extra Strength Caplets yesterday became the latest in a long succession of Johnson & Johnson products to be pulled from the shelves after complaints of the pills’ “musty odor”.
07-Jul-2011 By Gareth Macdonald
Parexel says strategic partnerships let pharmaceutical companies streamline how they work with contractors and are changing how CROs view outcomes.
Cadila sent warning letter after FDA finds microbiology probs
07-Jul-2011 By Nick Taylor
The FDA has sent a warning letter to Cadila Healthcare’s Ahmedabad, India finished products plant after an inspection found GMP deviations.
Quintiles to buy into Italian regulatory services sector
07-Jul-2011 By Gareth Macdonald
Contract research organisation (CRO) Quintiles says acquisition of Italy’s Temas will help it meet demand for market access services.